Table 2 Comparison of DAS28-SR and B-SR in the entire population
From: Patient’s perspective of sustained remission in rheumatoid arthritis
DAS28-SRa | B-SRa | p | |
|---|---|---|---|
N° (% [95% CI]) of patients who achieved SR | 78 (53.8 [46–62]) | 63 (43.4 [35–52]) | 0.000 |
Months of follow-up to SRb | 9.1 ± 5 | 10.9 ± 5.6 | 0.023 |
Months of SR durationb | 22.3 ± 5.7 | 17.5 ± 6.2 | 0.000 |